AJMC September 9, 2024
Eva Otter, president of Pulmonary Hypertension Association Europe, discusses the significance of shared decision-making for patients with pulmonary arterial hypertension.
It is important that patients with pulmonary arterial hypertension (PAH) have a voice in medical presentations and clinical trials, says Eva Otter, president of Pulmonary Hypertension Association (PHA) Europe.
Otter has been living with PAH for more than 20 years, and is a long-time survivor who is now in good health.
This transcript was lightly edited.
Transcript
Can you discuss the importance of shared decision-making for patients with PAH?
I would say in the new guidelines, we have to share decision-making. This is a very important point for me. Shared decision-making is when you are a well-informed patient, and you...
Today's Sponsors
Today's Sponsor